Life Sciences: The State of Data Integrity and Security
The Pharma IQ report, in collaboration with Dotmatics and BioBright, emphasizes the critical importance of data integrity, security, and encryption throughout the drug product lifecycle in life sciences, highlighting strategies such as automation and regulatory compliance to drive digital transformation and secure analytics in pharmaceutical research and development.
Ensuring Data Integrity, Security, and Encryption in Life Sciences
To ensure the safety, quality, and efficacy of a drug product prior to market roll out, it is critical that life sciences companies uphold the integrity and security of the data generated throughout an entire product’s lifecycle.
While advances in technology have propelled the life sciences industry forward, driving organizations to be data compliant will accelerate the use of secure analytics applications. This, in turn, fuels the digital economy in pharma and helps companies avoid risky outcomes.
Pharma IQ’s report, in collaboration with Dotmatics and BioBright, explores why pharmaceutical data integrity and data security are more important than ever in the life sciences industry.
“At the most macro level, there has been a race by every actor in biological research and clinical development to digitize information and to make analytics at scale possible.”
Charles Fracchia, CEO of BioBright & VP of Data at Dotmatics
Key Insights from the Report
- Strategies for data integrity and data security to enhance the digitization of the life sciences industry.
- How to improve data integrity and data security through automation.
- Approaches to overcoming regulatory challenges in digital transformation.
- Driving digital change in pharma business models by putting data security, data integrity, and encryption at the core of your data strategy.
Related
Prioritizing Data Integrity in R&D: Challenges and Best Practices
The article emphasizes the critical importance of maintaining data integrity in R&D by implementing robust data governance, security, and management practices throughout the research lifecycle to ensure data accuracy, protect patient safety, uphold product efficacy, and comply with regulatory standards amid increasing digitization and evolving threats.
The role of GxP compliance for safety and integrity
GxP compliance encompasses regulatory and quality guidelines such as Good Manufacturing Practices (GMP), Good Laboratory Practices (GLP), and Good Clinical Practices (GCP) established primarily by the FDA to ensure the safety, efficacy, traceability, and integrity of life science products and their supporting data throughout all stages of development, manufacturing, control, storage, and distribution, with specific requirements varying by product type and country.
Why OneNote Falls Short as a Scientific Lab Notebook — and What to Use Instead
The article explains that while Microsoft OneNote is a convenient and low-cost note-taking tool some researchers use as a makeshift electronic laboratory notebook (ELN), it lacks essential scientific data management features, built-in validation, and structured organization, making it risky and unreliable for accurately capturing, labeling, and searching experimental research data.
Limitations of Existing Life Science Software—and the Opportunity to Evolve
Existing life science software tools like ELNs, LIMS, and SDMS, while essential for digitizing workflows and managing data, are limited by their siloed, non-real-time, and non-AI-integrated designs, presenting an opportunity to evolve by integrating them into unified, intelligent platforms—such as Dotmatics Luma—that enable connected, workflow-aware, multimodal scientific intelligence with adaptive workflows, real-time data flow, and cross-functional insights without replacing core systems.
Laboratory Compliance: Key Regulations and Automation
Laboratory compliance involves adhering to regulations set primarily by the U.S. Department of Health and Human Services' Office of the Inspector General, along with the FDA and DEA, requiring clinical labs to implement comprehensive policies and procedures—including standards of conduct to prevent fraud and waste, ensuring medical necessity of tests, regular review of standing orders, addressing OIG fraud alerts, and maintaining proper record retention—to ensure ethical, professional, and efficient laboratory operations.
Modern Electronic Laboratory Notebooks
Modern electronic laboratory notebooks (ELNs) are software tools that enhance traditional physical lab notebooks by providing secure, centralized, and accessible platforms for data entry, protocol management, collaboration, and specialized laboratory functions, thereby improving data management, auditing, and resource tracking in research environments.